Skip to main content
SECO 2026 Annual Congress Main banner

SECO 2025

AOA CE HOURS

COPE-PM

OD FL

OD IL

OD TX

AOA-PARA

NCLE

OPT AZ

OPT FL

OPT GA

OPT KY

OPT NC-CL/MGMT

OPT NV

OPT SC

OPT TN

501 - SECO Contact Lens Summit Part I - The Business of Contact Lenses: Boosting Practice Growth, Patient Satisfaction, and Profits

Wednesday, February 26, 2025
12:15 PM - 2:15 PM EST
Location: Georgia World Congress Center, Sidney Marcus Auditorium
CE Hours: 2
This lecture is designed to empower eye doctors and their teams to maximize the success of their contact lens practices. Participants will learn advanced methods for enhancing patient satisfaction and loyalty, improving practice management, and utilizing the latest contact lens technologies. The course will explore targeted marketing strategies for contact lens practices, effective communication skills, and operational tips to boost profitability.

Learning Objectives:

Upon conclusion of this activity, attendees will be able to:
  • Gain strategies for being more profitable with contact lenses in their practice
  • Discover new technologies in contact lenses that can increase utilization and revenue
  • Learn strategies for marketing their practice to attract new patients for contact lens services
  • Enhance communication skills that can help with presentation of options that will enable more contact lens fits and renewals
  • Identify strategies for how to promote and fit specific categories of lenses (ortho-k, multifocals, scleral lenses, etc…) that can enhance their practice image and help drive profits at the same time
  • Apply pearls from panel members as to improve patient loyalty and staff engagement in contact lens practice, both of which are integral to success
Disclosure(s):
Jason Jedlicka, OD: Bausch and Lomb: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Glaukos: Advisory Committee/Board Member (), Consulting Fees (); Lens dEsign solutions: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (), Royalty Recipient (); Oculus: Advisory Committee/Board Member (), Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); ovitz: Speaker's Bureau (honoraria or other compensation) ()
Melissa Barnett, OD: ABBOptical: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); AbbVie/Allergan: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Acculens: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Azura Ophthalmics: Advisory Committee/Board Member (); Bausch + Lomb: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); BCLA: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Bruder: Advisory Committee/Board Member (); Bruno Vision Care: Advisory Committee/Board Member (); CooperVision: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Dompe: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Epion: Advisory Committee/Board Member (); Gas Permeable Lens Institute: Advisory Committee/Board Member (); Johnson & Johnson Vision: Advisory Committee/Board Member (); Lentechs: Advisory Committee/Board Member (); Ocusoft: Advisory Committee/Board Member (); Orasis: Advisory Committee/Board Member (); Percept: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (); RVL: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Science Based Health: Consulting Fees (); Sjogren's Syndrome Foundation: Advisory Committee/Board Member (); STAPLE program: Speaker's Bureau (honoraria or other compensation) (); Tarsus: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Thea Pharma: Advisory Committee/Board Member (), Speaker's Bureau (honoraria or other compensation) (); Visus Therapeutics: Advisory Committee/Board Member (), Consulting Fees ()
Jason E. Compton, OD, FAAO: Alcon: Speaker's Bureau (honoraria or other compensation) ()
Caity Morrison, OD: Bausch + Lomb: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) (); Tarsus Pharma: Consulting Fees (), Speaker's Bureau (honoraria or other compensation) ()
Roxanne Achong-Coan, OD: CooperVision: Speaker's Bureau (honoraria or other compensation) (); Topcon: Speaker's Bureau (honoraria or other compensation) ()